Haleon Plc Form 6-K Summary
Business Context and Reporting Period
This Form 6-K filing by Haleon Plc, a global leader in consumer health, covers the month of May 2025. The report specifically details a transaction in the company's own shares executed under a share buyback programme announced on March 28, 2025.
Key Financial Metrics
The filing does not provide revenue, profit, cash flow, margin, debt, or liquidity metrics. It focuses exclusively on share repurchase activity.
| Metric | Value |
|---|---|
| Date of Purchase | May 15, 2025 |
| Shares Purchased | 840,928 |
| Highest Price Paid | 400.90 pence |
| Lowest Price Paid | 392.30 pence |
| Volume Weighted Average Price | 397.06 pence |
| Registered Share Capital | 9,013,413,058 ordinary shares |
| Treasury Shares Held | 4,080,205 |
| Voting Shares Outstanding | 9,009,332,853 |
Material Changes
Following the settlement of the repurchase, the number of ordinary shares with voting rights decreased to 9,009,332,853. This figure is the relevant denominator for shareholders determining notification requirements under the FCA's Disclosure Guidance and Transparency Rules.
Guidance, Outlook, and Risks
The filing contains no financial guidance, outlook, management commentary on operations, or discussion of risks and contingencies. It is a regulatory disclosure of a specific capital transaction. The announcement explicitly states it does not constitute an offer or solicitation for securities.
Key Facts for Investor Verification
- Verify the total number of shares repurchased to date under the March 28, 2025 Buyback Programme.
- Confirm the updated number of voting shares (9,009,332,853) for compliance with disclosure thresholds.
- Review the full trade breakdown available via the provided London Stock Exchange link for granular transaction data.
- Note that this filing does not contain operational or financial performance data for the period.